MEGLASSON MARTIN 4
4 · LIGAND PHARMACEUTICALS INC · Filed Feb 17, 2010
Insider Transaction Report
Form 4
MEGLASSON MARTIN
V-P, Discovery Research
Transactions
- Award
Common Stock
2009-02-15+9,000→ 76,000 total - Award
Common Stock
2010-02-15+20,000→ 96,000 total - Award
Non-Qualified Stock Option (right to buy)
2010-02-15+106,000→ 106,000 totalExercise: $1.66Exp: 2020-02-15→ Common Stock (106,000 underlying)
Footnotes (1)
- [F1]Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 2/15/10.